Related Experiment Video

Updated: Aug 17, 2026

Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo
10:39

Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo

Published on: March 8, 2018

Diabetic vascular complications

M E Cooper1, R E Gilbert, G Jerums

  • 1Department of Medicine, University of Melbourne, Victoria, Australia.

Clinical and Experimental Pharmacology & Physiology
|October 7, 1997
PubMed

Insights

Diabetic vascular complications, including nephropathy and heart disease, stem from metabolic and hemodynamic issues. Advanced glycation inhibition, like with aminoguanidine, shows promise in preventing these serious diabetic issues.

Area of Science:

  • Vascular biology and pathology
  • Diabetology
  • Pharmacology

Background:

  • Diabetic vascular complications are categorized into microvascular (nephropathy, retinopathy, neuropathy) and macrovascular (atherosclerosis-driven ischemic heart disease, cerebrovascular disease, peripheral vascular disease).
  • Metabolic and hemodynamic factors are believed to interact, contributing to the development of these complications.
  • Advanced glycation end-products (AGEs) are implicated in the pathogenesis of diabetic complications.

Purpose of the Study:

  • To explore the role of advanced glycation in diabetic vascular complications.
  • To evaluate the efficacy of aminoguanidine, an AGE inhibitor, in attenuating diabetic vascular complications.
  • To review the progression from experimental studies to clinical trials for therapeutic agents targeting diabetic complication pathways.

Main Methods:

  • Review of literature on diabetic vascular complications and pathogenesis.
  • Examination of experimental studies investigating the effects of AGE inhibition.
  • Analysis of data from large-scale clinical trials of therapeutic agents.

Main Results:

  • Advanced glycation is a significant pathway in diabetic complication development.
  • Aminoguanidine demonstrated an ability to attenuate the progression of various diabetic vascular complications in experimental models.
  • Findings from experimental studies have informed the design and execution of clinical trials.

Conclusions:

  • Targeting advanced glycation represents a promising therapeutic strategy for diabetic vascular complications.
  • Further clinical investigation is warranted to validate agents interfering with metabolic and hemodynamic pathways in diabetes management.

More Related Videos

Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tg(fli:EGFP) Zebrafish Retinal Vasculature10:07

Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tg(fli:EGFP) Zebrafish Retinal Vasculature

Published on: December 26, 2017

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice04:36

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...